Valerian Formula Tablets

Natural health product licensed in Canada

Licence holder: BioV Pharma Inc.
NPN or DIN-HM: 80067976
Status: Inactive licence
Licence date: 23 March 2016
Revision date: Not provided
Form: Comprimé
Route of administration: Orale
Application type: Officinale

If this product were sold in France

Dose déclarée au-delà d'une limite
Vitamine B6: up to 10.5 mg a day according to the dosing instructions published by Health Canada (1 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 2 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
Dose déclarée au-delà d'une limite
Zinc: up to 30 mg a day according to the dosing instructions published by Health Canada (1 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 15 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
Dose déclarée au-delà d'une limite
Magnésium: up to 430 mg a day according to the dosing instructions published by Health Canada (1 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 300 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
À vérifier
Zinc: up to 30 mg a day according to the dosing instructions published by Health Canada, above the limite de sécurité from EFSA for adults (25 mg a day). Le repère de l'EFSA porte sur l'apport total d'une journée, alimentation et compléments.
limite supérieure de sécurité (UL). EFSA, Overview on Tolerable Upper Intake Levels (version 11, August 2025), retrieved 21 October 2026.
À vérifier
Magnésium: up to 430 mg a day according to the dosing instructions published by Health Canada, above the limite de sécurité from EFSA for adults (250 mg a day). Pour ce nutriment, le repère de l'EFSA ne porte que sur les apports ajoutés (compléments, aliments enrichis), pas sur ce qu'apporte l'alimentation courante.
limite supérieure de sécurité (UL). EFSA, Overview on Tolerable Upper Intake Levels (version 11, August 2025), retrieved 21 October 2026.
Conditions légales
Valeriana officinalis L.: L'absence de valépotriates doit être prouvée par des rapports d'analyse. L'étiquetage doit comporter un avertissement déconseillant l'emploi aux enfants de moins de 12 ans.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and source	Per dosage unit, according to the source	Maximum per day, adult
Vitamine B6 Source : Chlorhydrate de pyridoxine	10.5 milligramme	10,500 µg
Zinc Source : Monométhionine de Zinc	30 milligramme	30,000 µg
N-acétyl-5-méthoxytryptamine Source : Mélatonine	3 milligramme	Not calculated
Passiflora incarnata Source : Fleur	100 milligramme	Not calculated
Magnésium Source : Aspartate de magnésium	430 milligramme	430,000 µg
Valeriana officinalis Source : Racine	430 milligramme	Not calculated

Non-medicinal ingredients

Dioxyde de silicium, Stéarate de magnésium

Recommended doses in Canada

Population	Age	Quantity per serving	Frequency
Adultes	Not specified	1 Comprimé	1 Tous les jours

Uses authorised in Canada

Helps increase the total sleep time (aspect of sleep quality) in people suffering from sleep restriction or altered sleep schedule, e.g. shift-work and jet lag. Traditionally used in Herbal Medicine as a sleep aid (in cases of restlessness or insomnia due to mental stress). An antioxidant for the maintenance of good health.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

Précautions et mises en garde
Consumption with alcohol, other medications or natural health products with sedative properties is not recommended . If you are taking one of the following medications, consult a health care practitioner prior to use: anticoagulant, anticonvulsant, blood pressure medications, immunosuppressive medications, sedative, hypnotic or psychotropic medications, or steroids. If you have one of the following conditions, consult a health care practitioner prior to use: asthma, cardiovascular disease, chronic kidney disease, depression, diabetes or hypoglycaemia, hormonal disorder, immune system disease, liver disease, migraine, or seizure disorders. Consult a health care practitioner if sleeplessness persists continuously for more than 3 weeks (chronic insomnia). Consult a health care practitioner if symptoms persist. Consult a health care practitioner if symptoms worsen. Consult a health care practitioner prior to use if you are pregnant or breastfeeding. Consumption with alcohol, other medications or natural health products with sedative properties is not recommended. Helps in energy metabolism and in tissue formation. Helps to maintain normal DNA synthesis.
Contre-indications
If you are pregnant or breastfeeding, do not use this product. Rare allergic reactions have been known to occur in which case, discontinue use.
Effets indésirables connus
Mild gastrointestinal symptoms (nausea, vomiting, or cramping) have been known to occur in which case, discontinue use. Hypersensitivity (e.g. allergy) has been known to occur; in which case, discontinue use. Some people may experience drowsiness. Exercise caution if operating heavy machinery, driving a motor vehicle or involved in activities requiring mental alertness.

Source

Official Health Canada record, licence 80067976

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.